semaglutide fda update New Weight Loss Medication Wegovy™ Approved by the The FDA's Decision to Ban

The Scientific Advisory Committee on Nutrition (SACN) advises that excessive saturated fat intake is associated with increased cardiovascular risk, whilst high salt consumption may elevate blood pressureconsiderations particularly relevant for individuals with obesity-related comorbidities

That said, the growing list of health benefits from GLP-1 agonists (see "Anti-obesity drug lowers heart-related problems" in the February 2024 Heart Letter ) may make them both more accessible and affordable in the future

This condition results in anemia, which can range from mild to severe

Fuke, N., Nagata, N., Suganuma, H

Cancer 77 , 288298 (2025)

Her professionalism as an MD really shines through, and I trust her completely